Business Context and Reporting Period
This Form 6-K filing by Icecure Medical Ltd. covers the month of January 2026, specifically reporting on a Special General Meeting of Shareholders convened on January 7, 2026.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions and does not contain financial performance data.
Material Changes
- Shareholders approved all agenda items outlined in the Proxy Statement filed on December 3, 2025.
- Amendments to the Company's Amended and Restated Articles of Association were approved and became effective immediately following the shareholder vote.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. The document serves solely to confirm the completion of the shareholder meeting and the effectiveness of the Articles of Association amendments.
Investor Verification Checklist
- Review Exhibit 99.1 to examine the specific text of the Amended and Restated Articles of Association.
- Refer to the Proxy Statement filed on December 3, 2025, for details on the agenda items that were approved.
- Confirm the incorporation of this report into the Company's active Registration Statements on Form F-3 and Form S-8.